HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Research Dictionary Pharma Mobile

Sign Up FREE or Login

diethylenetriamine

Subscribe to New Research on diethylenetriamine

RN given refers to parent cpd

Also Known As:

diethylenetriamine diacetate; diethylenetriamine hydrochloride; diethylenetriamine monohydrochloride; diethylenetriamine trihydrofluoride

Networked: 93 relevant articles (6 outcomes, 11 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 58
- Amines: 1422
  - Polyamines: 1386
    - diethylenetriamine: 93

Experts

1.	Dietzel, Matthias: 2 articles (03/2015 - 05/2010)
2.	Takamura, Manabu: 2 articles (06/2014 - 10/2010)
3.	Imai, Yasuharu: 2 articles (06/2014 - 10/2010)
4.	Igura, Takumi: 2 articles (06/2014 - 10/2010)
5.	Kogita, Sachiyo: 2 articles (06/2014 - 10/2010)
6.	Sawai, Yoshiyuki: 2 articles (06/2014 - 10/2010)
7.	Fukuda, Kazuto: 2 articles (06/2014 - 10/2010)
8.	Morimoto, Osakuni: 2 articles (06/2014 - 10/2010)
9.	Murakami, Takamichi: 2 articles (06/2014 - 10/2010)
10.	Hori, Masatoshi: 2 articles (06/2014 - 10/2010)

Related Diseases

1.	Vascular Diseases (Vascular Disease) 01/01/1999 - "These results suggest that clearance of diethylenetriamine pentaacetate is preserved in patients likely to have pulmonary vascular disease and may be useful in distinguishing fibrosing alveolitis from vascular disease in systemic sclerosis." 01/01/1999 - "This study evaluated the utility of the clearance time of inhaled diethylenetriamine pentaacetate (DTPA) to distinguish pulmonary vascular disease from early fibrosing alveolitis (FA) in patients with systemic sclerosis (SSc). "
2.	Thyroid Neoplasms (Thyroid Cancer) 10/01/1999 - "This study compared the toxicity and efficacy of 131I-labeled bivalent hapten pretargeted by anti-carcinoembryonic antigen (CEA)/anti-N alpha-(diethylenetriamine-N,N,N',N''-tetraacetic acid-indium(F6-734) bispecific antibody [affinity enhancement system (AES) reagents] with 131I-labeled anti-CEA F(ab')2 (131I-F6) in mice grafted with a human medullary thyroid carcinoma. "
3.	Systemic Scleroderma (Systemic Sclerosis) 01/01/1999 - "These results suggest that clearance of diethylenetriamine pentaacetate is preserved in patients likely to have pulmonary vascular disease and may be useful in distinguishing fibrosing alveolitis from vascular disease in systemic sclerosis." 01/01/1999 - "This study evaluated the utility of the clearance time of inhaled diethylenetriamine pentaacetate (DTPA) to distinguish pulmonary vascular disease from early fibrosing alveolitis (FA) in patients with systemic sclerosis (SSc). "
4.	Pulmonary Fibrosis (Hamman Rich Syndrome) 01/01/1999 - "These results suggest that clearance of diethylenetriamine pentaacetate is preserved in patients likely to have pulmonary vascular disease and may be useful in distinguishing fibrosing alveolitis from vascular disease in systemic sclerosis." 01/01/1999 - "This study evaluated the utility of the clearance time of inhaled diethylenetriamine pentaacetate (DTPA) to distinguish pulmonary vascular disease from early fibrosing alveolitis (FA) in patients with systemic sclerosis (SSc). "
5.	Lung Injury 08/01/1997 - "Lung clearance of 99mTc-labeled diethylenetriamine pentaacetate (DTPA) is a sensitive test of altered alveolar epithelial permeability that has been found to be increased in smokers of tobacco, as well as a small number of healthy smokers of crack cocaine, suggesting the possibility of subclinical crack-related lung injury. " 12/01/2013 - "Using a murine model of bleomycin-induced lung injury, we assessed the binding of intravenously administered (111)In-labeled αvβ6-specific (diethylenetriamine pentaacetate-tetra [DTPA]-A20FMDV2) or control (DTPA-A20FMDVran) peptide by nanoSPECT/CT imaging. "

Related Drugs and Biologics

1.	Pentetic Acid (DTPA)
2.	PENTA
3.	Acetic Acid (Vinegar)
4.	Indium
5.	Indicators and Reagents (Reagents)
6.	Carcinoembryonic Antigen
7.	Technetium (Technetium 99m)
8.	Coal
9.	Crack Cocaine
10.	Gadolinium

Related Therapies and Procedures

1.	Lasers (Laser)
2.	Induced Hyperthermia (Thermotherapy)
3.	Photochemotherapy (Photodynamic Therapy)
4.	First Aid (Aids, First)